Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | KCNB1 | Q14721 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | BCL2L11 | O43521 | 1/20 | 0.31 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.31 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26040182 | 0.78 | ESR1 (0.41) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL19420810 | 0.74 | NOS2 (0.38) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL25599636 | 0.74 | ESR1 (0.39) | — | |
| SCHEMBL18798080 | 0.73 | LOX (0.32) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL179528 | 0.72 | TAAR1 (0.42) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL27342160 | 0.71 | NOS3 (0.36) | — | |
| SCHEMBL14316703 | 0.70 | HRH1 (0.40) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL18783120 | 0.69 | TAAR1 (0.33) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL20738687 | 0.69 | CYP3A4 (0.41) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL17828010 | 0.69 | CYP3A4 (0.41) | KCNA5KCNB1CYP3A4CYP2D6SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180098983-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE, INC. | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180098983-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | PIK3CA, AKT3, PIK3C2A | KCNA5 3851/4885KCNB1 2890/4885CYP3A4 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.